Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

9.70HKD
7 Aug 2020
Change (% chg)

HK$-0.21 (-2.12%)
Prev Close
HK$9.91
Open
HK$9.91
Day's High
HK$9.91
Day's Low
HK$9.47
Volume
84,042,885
Avg. Vol
87,378,163
52-wk High
HK$11.24
52-wk Low
HK$5.91

Summary

Name Age Since Current Position

Y Y Tse

26 2015 Executive Chairwoman of the Board

Ping Tse

68 2016 Chief Executive Officer, Executive Director

Cheung Ling Cheng

56 2017 Executive Vice Chairwoman of the Board

Jiayin Ma

44 Group Chief Financial Officer

Xiquan Zhang

51 2019 Senior Vice President of CT Tianqing and the Director of the CT Tianqing R&D Institute

Chunling Li

48 Vice President - Finance of CT Tianqing

Fajun Cai

50 2019 Vice President of CT Tianqing and the General Manager of the oncology products department

Wenjun Shi

47 2019 Vice President of CT Tianqing and the General Manager of the integrated product lines department

Zhaocheng Tang

54 2019 Vice President of CT Tianqing, General Manager of LYG Runzhong

Minggang Wang

63 2019 Vice President and General Manager of CP Qingdao

Qiang Yao

48 2019 Vice President of CT Tianqing and the General Manager of the integrated product lines department (southern area) of CT Tianqing

Hsin Tse

50 Vice President, Executive Director

Mingqin Li

61 2015 Vice President, Executive Director

Yangsheng Chen

52 2019 Vice President in R&D of CP Qingdao

Fai Chia

62 2018 Assistant to the Founding Chairman and a Vice President

Wenjun Geng

49 Vice President of CT Tianqing

Fangzhui Hu

47 Vice President of CT Tianqing

Jinming Li

55 2016 Vice President of CT Tianqing

Ren Li

47 2018 Vice President of CP Qingdao

Songwu Lu

57 Assistant Vice President of of CT Tianqing

Hong Wang

56 2018 Vice President of CT Tianqing

Xiangjian Wang

49 Vice President of CT Tianqing

Chunguang Xia

49 Vice President of CT Tianqing

Ling Yang

52 Vice President of CT Tianqing

Wei Zhao

43 Vice President of CT Tianqing

Xinglong Zhuang

50 2016 Vice President of CT Tianqing

Zhoushan Tian

56 2019 General Manager of NJCTT, Executive Director

Wenyu Xia

51 2014 General Manager and Director of Jiangsu Fenghai

Wei Nong Ye

57 2018 Assistant to the Founding Chairman and General Manager of the R&D Department

Yong Zhu

53 2015 General Manager of Jiangsu Qingjiang

Sheng Chen

40 2019 Deputy General Manager and the Financial Controller

Haihua Liu

56 Deputy General Manager - of Jiangsu CT Fenghai

Kuanqi Wang

53 2016 Senior Deputy General Manager - NJCTT

Kangxin Yu

41 Deputy General Manager of CT Tianqing

Ling Zhang

46 Deputy General Manager and the Secreatary to the board of directors of NJCTT

Yangqing Zhang

51 Deputy General Manager of Finance Department of NJCTT

Zhenqian Zhang

50 Executive Deputy General Manager - NJCTT

Zhaobo Zhong

51 Deputy General Manager of LYG Runzhong

Chunxia Zhu

43 Deputy General Manager of NJCTT

Yongqiang Zhu

43 Deputy General Manager of Jiangsu CT Fenghai

Chau Ling Yu

51 Assistant Vice President, Financial Controller

S Y Tse

24 2019 Executive Director

Shanchun Wang

52 2015 Executive Director

Shanhai Cao

49 Director and the Party Secretary of Beijing Tide

Haiyan Chen

51 Vice President of Beijing Tide

Qishun Hu

57 Vice President of Beijing Tide

Yujing Liu

54 Vice President of Beijing Tide

Zong Liu

55 Senior Engineer

Zhanqiang Shang

44 General Manager of Nanjing Shunxin Pharmaceutical

Yuhang Sun

40 Vice President of Beijing Tide

Wun Tse

53 2018 Assistant to the founding chairman

Hongqi Wang

54 Deputy General Manager of NJCTT

Yong Yang

47 Vice President of Beijing Tide

Jie Zhang

49 Vice President - CT Tianqing.

Hailiang Zhao

41 Vice President of Beijing Tide

Yanping Zhao

38 Vice President of Beijing Tide

Yaojie Zhu

50 Vice President of Beijing Tide

Oi Nin Chan

52 2015 Company Secretary

Dakui Li

76 2004 Independent Non-Executive Director

Hong Lu

50 2015 Independent Non-Executive Director

Zhengfei Lu

56 2005 Independent Non-Executive Director

Lu Fu Zhang

63 2015 Independent Non-Executive Director

Biographies

Name Description

Y Y Tse

Ms. Tse Y Y serves as Executive Chairwoman of the Board of the Company. She Miss Tse is also a director of CT Tianqing and the vice chairlady of Beijing Tide. Miss Tse is currently a non-executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited (listed on GEM of the Stock Exchange) and a director of Karolinska Development AB (publ) (listed on NASDAQ Stockholm Exchange). She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the investment, finance and business development departments of several companies. As a new generation business leader, Miss Tse was recognized as one of the “Most Outstanding Business Women in China for 2018” by Forbe China online. Miss Tse is the daughter of M r. Tse Ping and Ms. Cheng Cheung Ling, both being Executive Directors and substantial shareholders of the Company, and a niece of each of M r. Tse Hsin, an Executive Director of the Company, Ms. Chia Fai, Miss Tse Wun, and M r. Tse Hsuan, Johnny, all being senior management of the Company.

Ping Tse

Mr. Tse Ping serves as Chief Executive Officer, Executive Director of the Company. He is the founding chairman of the Company and now serves as the Chief Executive Officer of the Company. He is responsible for the overall operations of the Group. With more than 27 years of extensive experience in investment and management in the pharmaceutical industry in China, he is currently a director of CT Tianqing, Beijing Tide, NJCTT, Jiangsu CT Fenghai, Jiangsu CT Qingjiang, and CP Qingdao. He is also a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd., Chia Tai Oversea Chinese Realty Development Co., Ltd., and Karolinska Development AB (publ) (listed on NASDAQ Stockholm Exchange), and was the Chairman of the board of director and an executive director of Lamtex Holdings Limited (listed on the Stock Exchange). Mr. Tse still serves as a director of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. and a council member of the Association of Pharmaceutical Biotechnology of China.

Cheung Ling Cheng

Ms. Cheng Cheung Ling serves as Executive Vice Chairwoman of the Board of the Company. She is the chairwoman of Beijing Tide and CP Qingdao. Ms. Cheng graduated from the Guanghua School of Management of Peking University and obtained a Master Degree in Business Administration. She is a also clinician. Ms. Cheng is one of the founders of CP Pharmaceutical Group and has made significant contribution to the development of business of the group in China. Having extensive experience in and a discerning vision for management and investment in the pharmaceutical industry, she spares no effort in promoting innovation and R&D capabilities in the industry. Being at the helm of Beijing Tide, Ms. Cheng advocates for innovations in R&D, production, sales, and management, and has led Beijing Tide to step up its efforts in developing international collaboration, with an aim to promote the rapid development of cutting-edge technologies for medical products in China. Under her leadership, Beijing Tide has achieved tremendous growth, riding on internationalization and innovation. Beijing Tide has become a leading company for the development of targeted drugs in China, ranked 41st among the “Top 100 Pharmaceutical Companies in China” for 2018 (awarded by the China National Pharmaceutical Industry Information Center) and recognized as an “Outstanding Industrial Enterprise for Pharmaceutical R&D Pipelines in China” for 2019 (awarded by the National Pharmaceutical Industry Information Annual Conference).

Jiayin Ma

Ms. Ma Jiayin serves as Group Chief Financial Officer of the Company. She is responsible for financial matters of the Group. Ms. Ma obtained her MBA from Columbia Business School and Bachelor of Science from New York University Stern School of Business. She is a Certified Public Ac-countant and a CFA Charterholder, and has over 20 years of experience with large multinationals in various accounting and finance capacities.

Xiquan Zhang

Mr. Zhang Xiquan serves as Senior Vice President of CT Tianqing and the Director of the CT Tianqing R&D Institute of the Company. Mr. Zhang graduated from the chemistry department of Nankai University with a Master of Science degree in 1994. He takes charge of a number of studies of new drugs with expertise in drug candidate selection and joint development with collaborators. Mr. Zhang joined CT Tianqing in April, 1997. Being a leader of R&D of CT Tianqing, he was inducted into talents development programmes including Jiangsu Province Young and Middle Aged Experts with Outstanding Contribution, Six Categories of Talents Summit, and Jiangsu Province 333 Talents Project, awarded the National Technology Advancement Second Honour Award, the Jiangsu Province Technology Advancement Second Honour Award, and the Shanghai Technology Advancement Second and Third Honour Awards, and granted the State Council special allowance.

Chunling Li

Ms. Li Chunling serves as Vice President - Finance of CT Tianqing of the Company. She is a vice president of CT Tianqing. She is responsible for finance and informatisation of CT Tianqing, as well as the rules setting, team building, and platform construction for the bidding and procurement committee of the company. Ms. Li graduated from Guizhou College of Finance and Accounting, and is a senior accountant and a certified accountant in the PRC. She had worked in audit firms and joined the Group in 1996. Ms. Li has over 20 years of experience in finance and accounting, and more than 10 years of experience in informatisation.

Fajun Cai

Mr. Cai Fajun serves as Vice President of CT Tianqing and the General Manager of the oncology products department of the Company. Mr. Cai studied drug analysis in Wuxi Medicine College and graduated from the Beijing Technology and Business University with a Bachelor degree in management. Mr. Cai joined the Group in April, 1997, and had been working in production and sales departments. He has nearly 30 years of practical experience in medicine production and sales, and has shrewd market acumen and rich sales and management experience.

Wenjun Shi

Mr. Shi Wenjun serves as Vice President of CT Tianqing and the General Manager of the integrated product lines department of the Company. Mr. Shi studied Chinese Language in Nanjing Normal University and obtained a Master degree in human resources management from Xiamen University. Mr. Shi joined the Group in April, 1997 and had been a director and a deputy general manager. He has over 20 years of experience in sales and management of pharmaceutical products, having shrewd sense of market conditions and insightful and precise views.

Zhaocheng Tang

Mr. Tang Zhaocheng serves as Vice President of CT Tianqing, General Manager of LYG Runzhong of the Company. Mr. Tang joined CT Tianqing in April, 1997. He has a professional qualification in chemical engineering. Mr. Tang has been engaged in medicine production for more than 20 years, and has extensive experience in pharmaceutical production, quality management, and process advancement. He was awarded as a National Advanced Individual in Quality Control and a Jiangsu Province Outstanding Entrepreneur and was granted special allowance by the Lianyungang government.

Minggang Wang

Mr. Wang Minggang serves as Vice President and General Manager of CP Qingdao of the Company. Mr. Wang joined the Group in September, 2008. He had worked in some large domestic and foreign pharmaceutical companies and was the general manager of Qingdao Haier Pharmaceutical Co. Ltd and the head of the biological division of the Haier Group. He has more than 30 years of management experience in pharmaceutical industry. Mr. Wang is the chairman of Qingdao Pharmaceutical Profession Association, a vice chairman of the Shandong Province Pharmaceutical Profession Association, and was a deputy of the 15th and 16th Municipal People’s Congress of Qingdao City. Mr. Wang has received various recognitions in recent years, such as Qingdao Distinguished Talent, Shandong Province Technology Advancement Second Honour Award, Qingdao Technology Advancement Third Honour Award, Shangdong Province Invention and Entrepreneurship First Honour Award, one of the Top 10 Entrepreneurs of Zhongde Industrial Park, and a Leader in Brand Building for “Quality Shandong Pharmaceuticals”.

Qiang Yao

Mr. Yao Qiang serves as Vice President of CT Tianqing and the General Manager of the integrated product lines department (southern area) of CT Tianqing. He graduated from Nanjing Tech University and further studied in East China University of Science and Technology to obtain an MBA degree. Mr. Yao joined the Group in April, 1997 and had been a sales director and a deputy general manager. He has extensive practical experience in sales and management, with advanced team management concepts and innovative sales management methods.

Hsin Tse

Mr. Tse Hsin serves as Executive Director, Vice President of Sino Biopharmaceutical Ltd. He is an executive director and a vice president of the Company. He is mainly responsible for the acquisition and merger activities of the Group. He is also the Group’s spokesman. Mr. Tse Hsin graduated from the University of Hong Kong with a Bachelor’s Degree (Honors) in Industrial Engineering. He joined the Group in August, 1995 as an assistant to the president of the Company and served as the general manager of Xian C.P. Pharmaceutical Co., Ltd. Mr. Tse Hsin was a council member of the first council and the executive council member of the second council of Chaozhou Natives Chamber of Commerce Beijing. He is also an executive member of the Right Protection Association for the Medical Treatment Equipment Enterprises of the Shaanxi Province, the vice chairman of the fourth council of the Foreign Invested Enterprises Association of the Shaanxi Province, the executive member of the third committee of the Shaanxi Cancer Fighting Association and the vice chairman of the World Chinese Medicine and Pharmaceutical Professional Joint Committee. He was awarded the “Outstanding Management Award for Foreign-invested Enterprises of Shaanxi Province” by the Shaanxi Provincial Government and the “Outstanding entrepreneur who cares about his staff” by the Shaanxi Foreign Invested Enterprises Association. He was a director of CT Tianqin and Beijing Tide, and is currently a director of NJCTT and CP Qingdao, a supervisor of CT Tianqing, and the president of Chia Tai Shaoyang Orthopedic Hospital. He is an uncle of Ms. Tse, Theresa Y Y and Mr. Tse, Eric S Y and a first cousin of Mr. Tse Ping, all being executive directors and substantial shareholders of the Company. He is also the brother of Miss Tse Wun and a first cousin of Ms. Chia Fai, senior management of the Company.

Mingqin Li

Ms. Li Mingqin serves as Vice President, Executive Director of Sino Biopharmaceutical Ltd. She is currently a vice president of the Company and a director of Beijing Tide, Chia Tai Shaoyang Orthopedic Hospital, CP Boai Investment Ltd., and Jiangsu CT Qingjiang, and is principally responsible for the investment affairs of the Group. Ms. Li graduated from the Faculty of Medicine of Beijing Chinese Medicine University with a Bachelor Degree in medicine. Prior to joining the Company, Ms. Li had worked in Sino-Japanese Friendly Hospital and Beijing Chinese Medicine University, engaged in teaching of medicines, development of new medicines and medicine management. During the period from 1992 to 1995, Ms. Li had been engaged in post-doctorate research in the Medicine School of University of Colorado, USA and the Medical College of the University of Massachusetts. Ms. Li joined the Group in March, 1997 and has 37 years of experience in the pharmaceutical industry.

Yangsheng Chen

Mr. Chen Yangsheng serves as Vice President in R&D of CP Qingdao of the Company. Mr. Chen graduated from chemistry department of Wuhan University and is a postgraduate student, a practicing pharmacist, and a research associate. He is a vice president in R&D of CP Qingdao. Mr. Chen was engaged in new drugs development with the National Institute of Pharmaceutical Research and Development Center after his graduation in 1993, and joined the then Qingdao Haier Pharmaceutical Co. Ltd. as the head of R&D in 1998. He has more than 25 years of experience in new drugs development and management. Mr. Chen is a review expert of the national provincial level technology projects, an executive vice chairman of the medicinal chemistry specialist committee of Qingdao Pharmaceutical Association, and a council member of Qingdao Marine Biomedical Technology Innovation Center. Awards and recognitions received by Mr. Chan in recent years include Qingdao Municipal Government Expert Special Allowance, Shandong Province Technology Advancement Second Honour Award, Qingdao Technology Innovation Second Honour Award, and Qingdao Technology Advancement Third Honour Award.

Fai Chia

Ms. Chia Fai serves as Assistant to the Founding Chairman and a Vice President of Sino Biopharmaceutical Ltd. Ms. Chia is an assistant to the founding chairman and a vice president of the Company. Ms. Chia joined the Group in November, 1991 and has more than 30 years of experience in finance and accounting. Ms. Chia is a director of various companies including Chia Tai Pharmaceutical (Lianyungang) Company Limited, Evon Industries Limited, Talent Forward Limited, Sino Biopharmaceutical (Beijing) Limited and Magnificent Technology Limited.

Wenjun Geng

Ms. Geng Wenjun serves as Vice President of CT Tianqing of the Company. Ms. Geng graduated from the Institute of Zoology of Chinese Academy of Sciences with a Master degree in science, and also obtained a Master degree in law from Chinese Academy of Social Sciences. As a qualified patent attorney, she is one of the second generation leaders in the field of intellectual property rights in China. Ms. Geng joined the Group in 2005, responsible for intellectual property rights management of CT Tianqing.

Fangzhui Hu

Mr. Hu Fangzhui serves as Vice President of CT Tianqing. Mr. Hu graduated from the finance department of Nanjing University of Finance & Economics in July, 1995. He is a certified accountant. Mr. Hu joined the Group in April, 1999, and has nearly 20 years of work experience. He has participated in and led many finance information platform projects and has extensive experience in management practices and finance informatisation.

Jinming Li

Mr. Li Jinming serves as Vice President of CT Tianqing of the Company. Mr. Li studied pharmacology at Chinese Pharmaceutical University, and holds an MBA degree awarded by Sun Yat-sen University. Mr. Li joined the Group in June, 2006 and is in charge of CT Tianqing University and the branding and communication center. He had worked as major district manager and deputy general manager in two well-known pharmaceutical enterprises in the PRC and has extensive sales and team management experience.

Ren Li

Ms. Li Ren serves as Vice President of CP Qingdao of the Company. She graduated from medicinal chemistry faculty of Ocean University of China and is a PhD fellow, a practicing pharmacist, and a senior engineer. She is a vice president of CP Qingdao. Ms. Ren joined the then Qingdao Haier Pharmaceutical Co. Ltd. in 1997 after her graduation, responsible for new drugs development, and had been the head of R&D, the head of marketing, and a deputy general manager of the company. She has gained more than 20 years of experience in pharmaceutical industry for new drugs development, marketing, production, quality control, and construction management. Ms. Ren is an executive vice chairman of the marine medicine specialist committee of Qingdao Pharmaceutical Association, an executive vice chairman of the medicine engineering specialist committee of Qingdao Pharmaceutical Association, and an executive member of the editorial board of the Chinese Journal of Osteoporosis. Awards and recognitions received by Ms. Ren in recent years include Distinguished Talent of Qingdao Xihaian New District, Shandong Province Technology Advancement Second Honour Award, and Qingdao Technology Advancement Third Honour Award.

Songwu Lu

Mr. Songwu Lu serves as Assistant Vice President of of CT Tianqing of the Company. Mr. Lu graduated from Jiangsu New Medical College with profession qualification in medical treatment. He joined the Group in April, 1997, and has over 20 years of management experience in pharmaceutical industry.

Hong Wang

Mr. Wang Hong serves as Vice President of CT Tianqing of CT Tianqing of the Company. Mr. Wang is a vice president of CT Tianqing. Mr. Wang finished his postgraduate studies in Shanghai Medical University with a Master degree in medical science in 1991, and also holds an MBA degree from the Business School of the National University of Singapore. Mr. Wang joined the Group in December, 2002, and was a director of marketing and a deputy general manager. He had been the Derm Franchise Sales Manager of Xian-Janssen Pharmaceutical Ltd. for 8 years. Mr. Wang has more than 20 years of experience in sales.

Xiangjian Wang

Mr. Wang Xiangjian serves as Vice President of CT Tianqing of the Company. He graduated from Nankai University and holds a Bachelor degree in molecular biology. Mr. Wang joined the Group in April, 1997 and is responsible for quality control of medicines, clinical monitoring and new medicine registration. He was inducted into the Lianyungang 521 talents development programme.

Chunguang Xia

Mr. Xia Chunguang serves as Vice President of CT Tianqing of the Company. He is a vice president of CT Tianqing, in charge of production, engineering, equipment, technology, EHS (environment, health & safety), and materials supply of CT Tianqing. He is also a deputy director of the CT Tianqing R&D Institute and the director of its Lianyungang branch. He is a researcher level senior engineer. Mr. Xia graduated from Wuhan University with a Bachelor degree in chemistry. Mr. Xia joined the Group in July, 1994 and held positions such as technician and deputy director of R&D institute. With more than 20 years of experience in development and production management of new drugs, he has led and participated in the development and production of dozens of new products of CT Tianqing.

Ling Yang

Ms. Ling Yang serves as Vice President of CT Tianqing of the Company. Ms. Yang graduated from the chemical engineering department of Tsinghua University, and after obtaining her Master degree from Nanjing Tech University, she was engaged in research and teaching in Nanjing Tech University. She joined the commercial sector for new drugs development after obtaining her PhD from Nanjing University in 2002. Ms. Yang subsequently joined the Group in 2005, responsible for the research and launch of new product development projects, external collaboration, and technology management for new drugs development of the CT Tianqing R&D Institute.

Wei Zhao

Mr. Zhao Wei serves as Vice President of CT Tianqing of the Company. He is a deputy director (vice president level) of the CT Tianqing R&D Institute and the director of the Innovative Biopharmaceuticals Institute of CT Tianqing, in charge of the R&D of biopharmaceuticals of CT Tianqing. He is a PhD holder, a researcher level senior engineer, and an industry professor of China Pharmaceutical University. Mr. Zhao joined the Group after graduation from China Pharmaceutical University in 2006. He successively led or participated in various key national new drug development projects, and has gained practical experience in the development and management of over a dozen of new biopharmaceuticals. He has been inducted into the Jiangsu Province 333 Talents Project.

Xinglong Zhuang

Mr. Zhuang Xinglong serves as Vice President of CT Tianqing of the Company. He graduated from Heilongjiang University of Chinese Medicine and holds a Bachelor degree in Chinese medicine. Mr. Zhuang joined the Group in April, 1997 and is currently responsible for the affairs related to the office of the board of directors of CT Tianqing, as well as sales and marketing management of the company. He is also the president of Lianyungang Chia Tai Tianqing Medicines Co., Ltd. and Suzhou Tianqing Xingwei Medicines Co., Ltd. and the deputy general manager of Chia Tai Tianqing Akeso (Shanghai) Biomedical Technology Company Limited, being in charge of the management of those wholly or non-wholly owned investees of CT Tianqing engaged in drugs distribution.

Zhoushan Tian

Mr. Tian Zhoushan serves as General Manager of NJCTT, Executive Director of the Company. Mr. Tian is currently the general manager of NJCTT. Mr. Tian completed MBA coursework in Nanjing University. He was the head of production, the assistant to the president, and the vice president of CT Tianqing, and has over 30 years of experience in the pharmaceutical industry.

Wenyu Xia

Mr. Xia Wenyu serves as General Manager and Director of Jiangsu Fenghai of the Company. He has a professional qualification in finance and accounting discipline at tertiary education level and is a Senior Economist. He graduated from the post-graduate MBA programme of the Renmin University of China. He has been the general manager and a director of Jiangsu CT Fenghai since September, 2014 and previously served as the head of finance department, deputy head of corporate restructuring committee, manager of financial planning department, board secretary, assistant to general manager and manager of logistic department, sales director, and deputy general manager of Jiangsu Fenghai. He has ample experience in corporate management, marketing, human resources and financial management, with over 30 years of experience in the pharmaceutical industry. He is the vice president of the Jiangsu Province Pharmaceutical Profession Association and a standing council member of the China Price Association and the Jiangsu Province Medical Insurance Committee, and was recognized as a distinguished entrepreneur of Yancheng City.

Wei Nong Ye

Dr. Ye Wei Nong is Assistant to the Founding Chairman and General Manager of the R&D Department of the Company. He is responsible for biotechnology development of the Group. He is currently a director of China Biotech & Drug Development Limited and Jiangsu CT Fenghai, and was a director of CPYH Biotechnology (Shanghai) Co., Ltd. In 1983, Dr. Ye graduated from Sun Yat-sen University with a Bachelor degree in biochemistry. In 1989, Dr. Ye obtained a doctoral degree in microbiology from the Institut National des Sciences Appliquees (INSA) de Toulouse of France. He also obtained a certificate of study for the post-graduate MBA programme of food technology and marketing from Ecole Superieure de Commerce (ESC) de Toulouse of France. Prior to joining the Group in July, 2002, he worked in Europe and Hong Kong for biotechnology and pharmaceutical companies. Dr. Ye was a member of the Advisory Committee on Applied Biology and Chemical Technology of The Hong Kong Polytechnic University from February, 2006 to September, 2014. He was also a council member of the 8th Subcommittee of Industrial Biochemistry and Molecular Biology under the Chinese Society of Biochemistry and Molecular Biology.

Yong Zhu

Mr. Zhu Yong serves as a General Manager of Jiangsu Qingjiang of the Company, He has been the marketing director of Jiangsu CT Fenghai since 2005, and is mainly responsible for marketing and academic promotion of new products, establishing the brand name of Fenghai and formulating successful marketing strategies for leading and developing market which resulted in the widespread recognition of the image of “New Model of Sugar Infusion Solution” of Jiangsu CT Fenghai by the pharmaceutical industry. In 2008, as a sales vice president, he initiated Jiangsu CT Fenghai’s characteristic mixed marketing model with success. In 2011, he was the executive vice president of Jiangsu CT Fenghai, responsible for R&D, marketing and human resources, having set up a drugs R&D centre in Nanjing and established the training system for all levels of staff. In October, 2014, he was appointed as the executive vice president of Jiangsu CT Qingjiang and was responsible for R&D, human resources and office administration. From January, 2015 onwards, he is the general manager and is responsible for overall management of Jiangsu CT Qingjiang, having successfully re-engineered its sales system, proposed the “RMB100 million” strategy for key products, and driven the sales of products like Glucosamine Hydrochloride and Cefaclor and Bromhexine Hydrochloride to exceed the RMB100 million targets. He was awarded a May 1 Labour Medal by the Huian City Peoples’ Government in 2015, and recognized as a Jiangsu Province Distinguished Manager for User Satisfaction and granted an advancement in technology award in 2017.

Sheng Chen

Mr. Chen Sheng serves as Deputy General Manager and the Financial Controller of the Company. He graduated from the accounting department of Nanjing University of Finance & Economics with a Bachelor degree in management, and is a certified registered tax agent in PRC, a certified accountant and a senior accountant. Mr. Chen joined Jiangsu CT Qingjiang in July, 2012 as an assistant to financial controller and is now a deputy general manager and the financial controller. During his tenure, Mr. Chen actively promotes the transformation and upgrade of finance management services to support sales activities with success. Under his management, the results of the company have continuously improved and the company was ranked as one of the top 50 tax contributors in the region in 2017. Mr Chen has extensive management experience in finance.

Haihua Liu

Mr. Liu Haihua is Deputy General Manager - of Jiangsu CT Fenghai of the Company. Mr. Liu studied chemistry in university, completed a postgraduate MBA programme of Renmin University of China, and in 2007, took part in the Thousand Talents programme of the Jiangsu Province in Hong Kong. He had been the head of equipment department, the head of production, an assistant to factory director, a deputy sales director, and a deputy director of production quality control. With over 20 years’ experience in management, he has profound knowledge in production quality control, corporate management, and project management, and has published various articles in major national journals.

Kuanqi Wang

Mr. Wang Kuanqi serves as Senior Deputy General Manager - NJCTT of the Company. Mr. Wang graduated from Changzhou Chemical Institute with profession qualification in organic synthesis. He joined CT Tianqing in 1988. He holds a Bachelor degree in pharmacology from China Pharmaceutical University and an EMBA degree from both of Shanghai Fudan University and National Taiwan University. He was an officer of production lines, a production manager, a director of production quality and an assistant to general manager. He has 32 years of experience in pharmaceutical industry.

Kangxin Yu

Mr. Yu Kangxin serves as Deputy General Manager of CT Tianqing of the Company. He is the deputy general manager (vice president level) of the tumor products division of CT Tianqing, in charge of sales of tumor products in the 4 major regions and 17 different provinces and cities in China. Mr. Yu graduated from Anhui University of Chinese Medicine with a Bachelor degree in Chinese medicine, and obtained an EMBA degree from Xi’an Jiaotong University and University of Texas at Arlinton. After joining the Group in 2001, he was successively engaged in different production and sales related positions including general manager of branch office and assistant to the president. With nearly 20 years of marketing and management experience in pharmaceutical industry, Mr. Yu has deep understanding of the pharmaceutical market in China.

Ling Zhang

Mr. Zhang Ling serves as Deputy General Manager and the Secreatary to the board of directors of NJCTT. Mr. Zhang graduated from the refined chemicals department of Zhengzhou Food Institute with a Bachelor degree in engineering. Mr. Zhang joined NJCTT in September, 2002, having served as a director of the general manager office, human resources director, assistant to general manager, etc., and has been the secretary to the board of directors since then. He has more than 10 years of experience in administration and human resources management, with profound knowledge of human resources management.

Yangqing Zhang

Mr. Zhang Yangqing serves as Deputy General Manager of Finance Department of NJCTT of the Company. He graduated from the engineering management faculty of Central South University with a Bachelor degree in industrial engineering management in 1990. He is a senior accountant, a certified accountant and a practicing registered real estate appraiser. He was a member of National Development and Reform Commission of Ziyang District of Yiyang City in Hunan Province, a civil servant of Housing Administrative Bureau of Yiyang City, an audit manager of Hunan Kaiyuan CPA, a financial controller of Chengdu Jiuzhitang Jinding Pharmaceutical Ltd., a deputy head of finance department and a director of marketing centre of Jiuzhitang Co., Ltd., the head of audit department of CT Tiangqing, finance manager of the Group, and a deputy general manager of finance department of Jiangsu CT Fenghai.

Zhenqian Zhang

Mr. Zhang Zhenqian serves as Executive Deputy General Manager - NJCTT of the Company. He is an engineer and holds an MBA degree. Mr. Zhang joined the Group in April, 1997 and is responsible for marketing and sales and operations of NJCTT. Graduated from Xuzhou College of Engineering, Mr. Zhang has completed the studies in EMBA program of Guanghua Management School of Peking University. Mr. Zhang was a branch manager and a major district manager of CT Tianqing and has over 20 years of experience in pharmaceutical industry.

Zhaobo Zhong

Mr. Zhong Zhaobo serves as Deputy General Manager of LYG Runzhong of the Company. He has profession qualification in chemical engineering. Mr. Zhong joined CT Tianqing in August, 1992. He has been engaged in pharmaceutical production for nearly 30 years, with extensive experience in process advancement, production, quality control management. He was awarded the Shanghai Science and Technology First Honour Award, and recognized as an Advanced Worker for Technology Progress in the Tenth Five-year Plan and one of the Top 10 Innovation Experts of Jiangsu Province.

Chunxia Zhu

Ms. Zhu Chunxia serves as Deputy General Manager of NJCTT of the Company. Ms. Zhu graduated from the refined chemicals department of Southeast University and obtained an EMBA degree from Peking University. She joined NJCTT in 2013, and had been a director of quality control and an assistant to the general manager, with extensive management experience.

Yongqiang Zhu

Mr. Zhu Yongqiang Ph.D. serves as Deputy General Manager of Jiangsu CT Fenghai of the Company.D. serves as Deputy General Manager of Jiangsu CT Fenghai of the Company. He is a PhD fellow and a professor in medicinal chemistry. Mr. Zhu obtained a doctoral degree from Peking University School of Pharmaceutical Studies and had been engaged in post-doctorate research in the University of Michigan, USA. He has been a deputy general manager of Jiangsu CT Fenghai since December, 2015. He was the vice president and president of the R&D Institute and an assistant to the general manager of Jiangsu CT Fenghai, and had worked as a director of laboratory of medicinal chemistry of Simcere Pharmaceutical Co., Ltd. He has more than 15 years of experience in pharmaceutical industry.

Chau Ling Yu

Ms. Yu Chau Ling CPA serves as Assistant Vice President, Financial Controller of the Company. She is an assistant vice president, the financial controller and the qualified accountant of the Company. She graduated from the University of Hong Kong with a Bachelor degree in social sciences and in 2005 obtained an MBA Degree from The Open University of Hong Kong. She is a fellow member and an associate member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants, respectively. Ms. Yu joined the Company in February, 2003 and has extensive working experience in international audit firm and listed companies.

S Y Tse

Mr. Tse S Y is Executive Director of the Company., since 23 October 2019. He is an executive director and a member of the executive board committee of the Company and a director of CT Tianqing. He holds a Bachelor of Science degree in Economics from the Wharton School of the University of Pennsylvania and a master degree in Management and Global Leadership from Schwarzman College, Tsinghua University. Before joining the Company in June 2018, Mr. Tse, Eric S Y served as the chief executive officer of Liepin North America, a reputable human resources company. Mr. Tse, Eric S Y founded the Penn Wharton China Summit during his time at university, and established the China Summit Foundation at the end of 2016. He was awarded the “Top Ten Outstanding Chinese American Youth” in 2018 (the list of which was jointly selected by the All America Chinese Youth Federation, the American Chinese Public Diplomacy Association, and the English “Los Angeles Post”). Mr. Tse, Eric S Y is the son of Mr. Tse Ping and Ms. Cheng Cheung Ling and the brother of Ms. Tse, Theresa Y Y, all being executive directors and substantial shareholders of the Company; a nephew of Mr. Tse Hsin, an executive director of the Company; and a nephew of each of Ms. Chia Fai and M iss Tse Wun, senior management of the Company.

Shanchun Wang

Mr. Wang Shanchun serves as Executive Director of Sino Biopharmaceutical Ltd. He graduated from Nanjing University of Chemistry in July, 1990 and joined CT Tianqing in the same year. Mr. Wang studied pharmaceutical engineering with Tianjin University from 1999 to 2002 and obtained a Master Degree. Mr. Wang has extensive management experience in the PRC pharmaceutical field. His design of the new production plant of CT Tianqing in Haizhou achieved a number of innovations in the country and obtained the first new edition national GMP certificate. He was awarded as a Jiangsu Province Technology Advanced Worker, a Jiangsu Province Model Labour, a winner of the Shanghai Technology Advancement First Honour Award, a Jiangsu Province Outstanding Entrepreneur, a Jiangsu Province Young and Middle-aged Expert with Outstanding Contribution, a Jiangsu Advanced Individual with Outstanding Contribution in Manufacture, and a National Distinguished Leader in Pharmaceutical Quality Management, and was elected as a delegate to Committee of the 13th Chinese People’s Political Consultative Conference of Jiangsu Province.

Shanhai Cao

Mr. Cao Shanhai serves as Director and the Party Secretary of Beijing Tide of the Company. Mr. Cao is an entrepreneur mentor for master degree students of Renmin University of China, a certified accountant in the PRC and a non-practicing member of the Chinese Institute of Certified Public Accountants. He graduated from Renmin University of China with a Master degree. Mr Cao joined Beijing Tide in January, 2013. He has many years of experience in financial management, internal audit and sales management.

Haiyan Chen

Ms. Chen Haiyan serves as Vice President of Beijing Tide of the Company. Ms. Chen graduated from the West Anhui University and holds a Master degree in Economics from Hefei University of Technology. After joining Beijing Tide in September, 1999, she started from the entry level up, having been engaged in sales, key customers liaison, government affairs, market access, and business affairs. She has rich experience in sales management.

Qishun Hu

Mr. Hu Qishun serves as Vice President of Beijing Tide of the Company. Mr. Hu is an executive member of the specialist committee on anesthesia of Chinese Research Hospital Association. He graduated from Southeast University with a Bachelor degree and obtained an MBA degree from Keele University, United Kingdom. Mr. Hu joined Beijing Tide in February, 2013 as a vice president and has rich practical experience in management practices.

Yujing Liu

Ms. Liu Yujing serves as Vice President of Beijing Tide of the Company. Ms. Liu is an expert adviser of Beijing Pharmaceutical Profession Association, and an expert of the inspection and review panel of Beijing Drug Certification Management Center. She graduated from Beijing University of Chemical Technology with a Bachelor degree. Ms. Liu joined Beijing Tide in June, 1995, and has been appointed as a vice president in 2016. She has extensive experience in management practices and has received two Beijing Science and Technology Second Honour Awards and a Daxing District Scientific Technology Advancement First Honour Award. Focusing on top-level design for manufacturing quality control system, she is committed to promoting and applying advanced practical quality control methods in an orderly and progressive way, and building a manufacturing quality control system for the company that is up to international standards.

Zong Liu

Mr. Liu Zong is Senior Engineer of the Company. Mr. Liu joined Jiangsu CT Qingjiang (previously known as Jiangsu Province Qingjiang Pharmaceutical Factory) in July, 1989. He was appointed as an assistant to general manager in 2000 and was responsible for quality control and new products development, helping the company obtain the GMP certificate for company relocation smoothly. He has been a deputy general manager and the secretary of board of directors of Jiangsu CT Qingjiang since 2004, being in charge of international trade of medicinal raw materials, product sales, and new products development and having successfully developed overseas market. He has rich experience in pharmaceutical industry.

Zhanqiang Shang

Mr. Shang Zhanqiang serves as General Manager of Nanjing Shunxin Pharmaceutical of the Company. Mr. Shang graduated from Jiangxi University of Science and Technology with a Bachelor degree in mechanical engineering and automation. He is a senior engineer, a senior manager, and a production operation manager. Mr. Shang joined the Group in July, 1999, and has 20 years of experience in production technology and management. He participated in and led multiple projects of production line planning, GMP certification and field audits for production of new products, acquiring rich experience in production technology and practical management.

Yuhang Sun

Mr. Sun Yuhang serves as Vice President of Beijing Tide of the Company. Mr. Sun graduated from Peking University in 2002 with a Bachelor degree in pharmacology and a Master degree in pharmaceutical engineering and holds an MBA degree jointly awarded by Tsinghua University and the Australian National University. He joined Beijing Tide in October, 2003. He had served as sales representative, district manager, major district manager, sales director, division general manager, and vice president, with extensive practical experience in management practices.

Wun Tse

Ms. Tse Wun serves as Assistant to the founding chairman of the Company. Ms. Tse joined the Group in November, 1991. She is mainly responsible for administration, finance and investment affairs of the Group’s Hong Kong office. Miss Tse graduated from the University of Oregon with a Bachelor of Science degree. She was formerly a director of Shenzhen 999 Pharmaceutical Co., Ltd. and has more than 20 years of experience in finance and investment.

Hongqi Wang

Mr. Wang Hongqi is a Deputy General Manager of NJCTT of the company. Mr. Wang graduated from the accounting faculty of Xuzhou School of Supply and Marketing and obtained a MBA degree from Nanjing University and a postgraduate diploma in MBA from Hong Kong Asia Business College. Mr. Wang joined CT Tianqing in July, 2002 and had been its branch manager, major district manager, and sales and marketing director. He has rich experience in sales and marketing management, with nearly 20 years of experience in pharmaceutical sales.

Yong Yang

Mr. Yang Yong serves as Vice President of Beijing Tide of the Company. Mr. Yang graduated from Capital University of Economics and Business with a Master degree in management. He is also a certified accountant in the PRC as well as Canada. After joining Beijing Tide in December, 2012, he held positions including director of the president’s office, sales director, vice president responsible for procurement and project management, and deputy director of finance of the company’s subsidiaries.

Jie Zhang

Mr. Zhang Jie serves as Vice President - CT Tianqing of the Company. He graduated from Nanjing University and holds an MBA degree. Mr. Zhang joined the Group in April, 1997 and is responsible for policy matters, tendering, human resources, legal affairs, and public relations of CT Tianqing. He holds positions in a number of pharmaceutical profession associations and has rich research results on national medicines policies, in particular the policies for medical insurance and healthcare reform.

Hailiang Zhao

Mr. Zhao Hailiang serves as Vice President of Beijing Tide of the Company. Mr. Zhao graduated from China University of Mining and Technology with a Bachelor degree. He joined Beijing Tide in November, 2009, and has more than 15 years of experience in investment.

Yanping Zhao

Mr. Zhao Yanping serves as Vice President of Beijing Tide of the Company. Mr. Zhao is a vice-chairman of Committee on Technology of National Biotechnology Standardisation, a director of LTT Bio-Pharma Co., Ltd., the person in-charge of the new preparations division of Beijing International Technology Cooperation Base, and a director of the Beijing Water Soluble Macromolecule Gel Patch Engineering Technology Research Center. He graduated from the pharmacy college of Shenyang Pharmaceutical University with a postgraduate Master degree. Mr. Zhao is responsible for a number of key national new drugs development projects of the Ministry of Science and Technology and some technology planning projects of the Beijing Municipal Science and Technology Commission, and was recognised as an Outstanding Young Talent in Beijing for 2015, a New Star of Technology in Beijing for 2017, and a Leading Figure of Innovative Engineering – Beijing Yiqilun for 2017.

Yaojie Zhu

Ms. Zhu Yaojie serves as Vice President of Beijing Tide of the Company. Ms. Zhu graduated from Beijing University of Technology with a Bachelor degree in 1992.She had been in charge of the cost accounting department of Beijing Jeep Automobile Co. Ltd, a deputy general manager of finance of each of Jiangsu CT Fenghai and Yancheng Suhai Pharmaceutical Co. Ltd., and a director of the audit department of Sino Biopharm. Ms. Zhu joined Beijing Tide in November, 2010.

Oi Nin Chan

Mr. Chan Oi Nin Derek is a Company Secretary of the Company since August, 2015. Mr. Chan has over 20 years of experience in accounting and auditing and, before joining the Company, was the company secretary of another company listed on the Stock Exchange. He is a fellow member of the Association of Chartered Certified Accountants and an associate member of the Hong Kong Institute of Certified Public Accountants. Mr. Chan received a Bachelor of Science degree from the Chinese University of Hong Kong in 1989 and an MBA degree from Monash University in 1995.

Dakui Li

Mr. Li Dakui serves as Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He graduated from the Faculty of Pharmacy of Beijing Medical University (now known as the School of Pharmaceutical Sciences of Beijing University) in 1965, and obtained a Master Degree in Pharmaceutics from Peking Union Medical College (“PUMC”) in 1982. He used to be the chief pharmacist of PUMC Hospital (retired in 2013) and the director of Pharmacy Department of PUMC Hospital for years. Mr. Li was a vice president of the Chinese Pharmaceutical Association, the Chairman of the Committee of Hospital Pharmacy Branch of Chinese Pharmaceutical Association and the vice chairman of the Chinese Practicing Pharmacist Association. He is currently an advisory member of the Chinese Pharmaceutical Committee and a vice president of the Beijing Pharmaceutical Association.

Hong Lu

Ms. Lu Hong serves as Independent Non-Executive Director of the Company. Ms. Lu has over 20 years of experience in accounting, financial management, company secretary and domestic and overseas capital operations fields. She is a member of the Chinese Institute of Certified Public Accountants and the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. Ms. Lu has extensive knowledge of PRC and international accounting standards and the listing rules and regulations of both Hong Kong and PRC. She has been in charge of or involved in the entire process of the listing of multiple corporations in the PRC, Hong Kong, Singapore and the United States of America and quite a number of foreign and domestic investment and financing operations as well as mergers and acquisitions. She is familiar with financial analysis, budgeting, financial management and tax planning. She also has expertise in dealing with complex financing and taxation matters. Ms. Lu is an independent non-executive director of Huan Yue Interactive Holdings Limited which is listed on the Stock Exchange.

Zhengfei Lu

Mr. Lu Zhengfei is a Independent Non-Executive Director of Sino Biopharmaceutical Ltd. He received a P.h.D. Degree in Economics (financial management). Mr. Lu is currently a Distinguished Professor of Chang Jiang Scholars and supervisor of doctoral students of the Guanghua School of Management of Peking University. He had previously held various senior positions in the Department of Accounting of both the Guanghua School of Management of Peking University and the Nanjing University. He is a standing council member of the China Accounting Association and the deputy director of its Financial Management Committee and was also an expert consultant of the China Financial Accounting Standards Board, Ministry of Finance. Mr. Lu is the editor of several accounting and finance journals and has issued various publications. He is an independent director of China Cinda Asset Management Co., Ltd. and an independent supervisor of PICC Property and Casualty Company Limited, both companies being listed on the Stock Exchange, and was an independent director of Bank of China Limited (listed on the Stock Exchange) and China Nuclear Engineering & Construction Corporation Limited (listed on Shanghai Stock Exchange).

Lu Fu Zhang

Mr. Zhang Lu Fu serves as a Independent Non-Executive Director of the Company. Mr. Zhang holds a Master Degree in Philosophy from the Beijing Normal University, and is currently a research associate and a part-time professor. Mr. Zhang has been working for multiple sectors of the Chinese government since 1987, including the Hong Kong branch of the Xin Hua News Agency (now known as Liaison Office of the Central People’s Government in Hong Kong). Mr. Zhang has worked for a number of Hong Kong listed companies and charitable organisations on full-time and part-time bases. Mr. Zhang is a council member of the China Overseas Friendship Association, a standing council member of the Guangdong Overseas Friendship Association, a standing council member of the Shenzhen Overseas Friendship Association, and a part-time professor of the Hong Kong Academy of Management, and was a member of the Shenzhen Committee of the 4th Chinese People’s Political Consultative Conference. Mr. Zhang is an independent non-executive director of Kingboard Laminates Holdings Limited and CT Environmental Group Limited, both being listed on the Stock Exchange.